DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
TAVT-18 (sirolimus)
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
158
結節性硬化症
1
158. 結節性硬化症
臨床試験数
:
112
/
薬物数
:
71
- (
DrugBank
:
19
) /
標的遺伝子数
:
35
-
標的パスウェイ数
:
118
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT04595513
(
ClinicalTrials.gov
)
September 8, 2020
20200908
6/10/2020
20201006
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Tuberous Sclerosis Complex;Epilepsy
Drug:
TAVT-18
(sirolimus)
Children's Hospital Medical Center, Cincinnati
NULL
Active, not recruiting
N/A
6 Months
All
5
Phase 1/Phase 2
United States